Anti 2019-nCoV

Biotechnological Products & Supplies

Updated on Apr 30, 2020

View more like this | Visit SHIRLEY, NY | Contact Dgwei Logepegeez
Image for Anti 2019-nCoV with ID of: 4198649
The mysterious coronavirus outbreak in the Chinese city Wuhan, and its fast spread to many other countries, endanger thousands of lives. The pandemic has catalyzed the drug development for the treatment of SARS-CoV-2. With years of experience in the research of nucleoside analogue inhibitors for the treatment of coronavirus, Creative Biolabs is confident in tailoring BCX4430 (galidesivir) validation service for the treatment of SARS-CoV-2 in a reliable and cost-effective manner.
goodideazs, LLC is not affiliated with the authors of this post nor is it responsible for its content, the accuracy and authenticity of which should be independently verified.